About this poster
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is a powerful, non-radioactive tool used in radioligand drug discovery for quantifying metal-conjugated peptides with high accuracy in radioligand drug discovery. This poster outlines IRBM’s systematically validated ICP-MS workflow, applied to Lutetium-labeled candidates to support targeted radiotherapy research. The established platform enables sensitive measurement of cellular uptake, distribution, and pharmacokinetics across a range of biological samples—accelerating early-stage evaluation without the complexity of radioactive assays. Discover how integrating ICP-MS facilitates robust analysis for oncology-focused radiotheranostic programs and streamlines the path to clinical translation.
Get the full poster
Free PDF, sent to your work email.
Peptide ICP-MS poster, code 25024